insights_auto
Why is EDIT down 3.01%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.77
arrow_downward
-3.01%(-0.055) 1D
$1.81
arrow_upward
+2.26% (+0.040)bedtimeAfter hours
Closed: Nov 18, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.86
High
$1.94
Low
$1.76
Mkt. cap
272.43M
Avg. vol.
2.39M
Volume
1.99M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.86
High
$1.94
Low
$1.76
Mkt. cap
272.43M
Avg. vol.
2.39M
Volume
1.99M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
BeInCrypto
·
1 hour ago
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
FXStreet
·
5 hours ago
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BigGo Finance
·
9 hours ago
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
Traders Union
·
1 hour ago
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com